Nonstandard and off-label therapies for psoriasis

Research output: Contribution to journalArticlepeer-review

43 Scopus citations


Although most psoriasis patients respond to standard therapies, many circumstances warrant the use of nonstandard or off-label treatments. For instance, patients with treatment-resistant psoriasis or those who have had multiple adverse effects to other therapies may be good candidates for off-label treatments. Similarly, patients with unusual and hard-to-treat forms of psoriasis such as pustular psoriasis and palmoplantar psoriasis or specific comorbidities may benefit from certain nonstandard therapies. Drugs that may be used as alternatives to standard therapies include mycophenolate mofetil, tacrolimus or pimecrolimus, isotretinoin, colchicine, sulfasalazine, paclitaxel, dapsone, azathioprine, and hydroxyurea. Other unconventional therapies include climatotherapy at the Dead Sea and grenz ray therapy.

Original languageEnglish
Pages (from-to)546-553
Number of pages8
JournalClinics in Dermatology
Issue number5
StatePublished - Sep 2008


Dive into the research topics of 'Nonstandard and off-label therapies for psoriasis'. Together they form a unique fingerprint.

Cite this